US
U.S. Physical Therapy, Inc.
USPH · NYSE
$83.13 +0.82% (+$0.68)
1M +6.55%
Market Cap $1.26B
P/E Ratio -
Div. Yield 2.20%
ROE 1.27%
Bulios Fair Price
$62.14
25.2% downside
Current Price
$83.13
Undervalued Fair Value Overvalued
According to Bulios Fair Price, USPH is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
62 /100
Fair P/B 2.82x
EV/EBITDA 16.20x
P/FCF 19.72x
Growth
50 /100
Stable FCF growth 6.64%
EPS growth 24.81%
Book val. growth 14.69%
Profitability
36 /100
Moderate Op. margin 10.81%
Gross margin 19.17%
FCF margin 8.22%
Quality
19 /100
Poor ROA 0.48%
ROIC 5.25%
Asset turnover 0.62x
Debt
51 /100
Moderate Int. coverage 7.27x
Debt/Equity 0.86x
Net debt/EBITDA 3.60x
Stability
73 /100
Stable EPS volatility 53.32%
Beta 1.13x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about USPH
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Christopher J. Reading
Employees
6,374
Headquarters
Houston
Upcoming events
04 NOV
Earnings
Upcoming earnings report